This bill aims to amend the Code of West Virginia by introducing five new sections that mandate insurance coverage for biodentical hormones. Specifically, it requires all insurers providing sickness or health care to include coverage for biodentical hormones in their policies, effective January 1, 2025. The coverage must be provided when deemed medically necessary and ordered by a licensed physician following a thorough evaluation of the patient's symptoms, diagnostic test results, or response to treatment. The new sections are designated as 33-15-4y, 33-16-3aaa, 33-24-7z, 33-25-8w, and 33-25A-8z, and they apply to various types of health insurance policies, including group accident and sickness insurance, hospital service corporations, health care corporations, and health maintenance organizations.

The bill does not delete any existing legal language but adds comprehensive requirements for insurers to ensure that biodentical hormones are covered under health insurance policies. This legislative change is intended to enhance access to necessary medical treatments for patients who require biodentical hormone therapy, thereby improving their overall health care options.

Statutes affected:
Introduced Version: 33-15-4y, 33-16-3aaa, 33-24-7z, 33-25-8w, 33-25A-8z